Italy’s health regulator is reportedly seeking damages worth nearly$2 billion from three of the world’s largest pharmaceutical firms for their repeated antitrust violations and subsequent harm on the nation’s health industry.

According to reports, the nation’s health ministry announced Wednesday it is seeking about $1.6 billion in damages from Novartis and …read more

Source: Global Competition Law Blogs